Modelling a disease-relevant contact network of people who inject drugs

Social Networks

Volumn 35, Issue 4, 2013, Pages 699-710

  Rolls, David A ^a   Wang, Peng ^a   Jenkinson, Rebecca ^b   Pattison, Phillipa E ^a   Robins, Garry L ^a   Sacks Davis, Rachel ^b   Daraganova, Galina ^a   Hellard, Margaret ^b   McBryde, Emma ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BURNET INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Exponential random graph model; Hidden population; Network size; Snowball sample; Social network

Indexed keywords

EID: 84887822273     PISSN: 03788733     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socnet.2013.06.003     Document Type: Article

References (57)

1. Aitken C., Lewis J., Tracy S., Spelman R., Bowden D., Bharadwaj M., Drummer H., Hellard M. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 2008, 48:1746-1752.
2. Aitken C., McCaw R.F., Bowden D., Tracy S., Kelsall J., Higgs P., Kerger M., Nguyen H., Crofts J. Molecular epidemiology of hepatitis C virus in a social network of injection drug users. Journal of Infectious Disease 2004, 190:1586-1596.
3. Aitken C.K., Lewis J.A., Hocking J.S., Bowden D.S., Hellard M.E. Does information about IDUs' injecting networks predict exposure to the hepatitis C virus?. Hepatitis Monthly 2009, 9:17-23.
4. Bansal S., Grenfell B.T., Meyers L.A. When individual behaviour matters: homogeneous and network models in epidemiology. Journal of the Royal Society Interface 2007, 4:879-891.
5. Brewer D.D., Hagan H., Sullivan D.G., Muth S.Q., Hough E.S., Feuerborn N.A., Gretch D.R. Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors. Journal of Infectious Disease 2006, 194:764-772.
6. Daraganova G., Pattison P., Koskinen J., Mitchell B., Bill A., Watts M., Baum S. Networks and geography: modelling community network structures as the outcome of both spatial and network processes. Social Networks 2012, 34:6-17.
7. De P., Cox J., Boivin J., Platt R., Jolly A. Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks. Journal of Acquired Immune Deficiency Syndromes 2007, 46:355-361.
8. De P., Roy E., Boivin J.F., Cox J., Morissette C. Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. Journal of Viral Hepatitis 2008, 15:279-292.
9. Dietze P., Jenkinson R., Aitken C., Stoové M., Jolley D., Hickman M., Kerr T. The relationship between alcohol use and injecting drug use: impacts on health, crime and wellbeing. Drug and Alcohol Dependence 2013, 128:111-115. 10.1016/j.drugalcdep.2012.08.013.
10. Esposito N., Rossi C. A nested-epidemic model for the spread of hepatitis C among injecting drug users. Bisoscience 2004, 188:29-45.
11. Frank O., Snijders T. Estimating the size of hidden populations using snowball sampling. Journal of Official Statistics 1994, 10:53-67.
12. Frank O., Strauss D. Markov Graphs. Journal of the American Statistical Association 1986, 81:832-842.
13. Friedman S.R., Furst R.T., Jose B., Curtis R., Neaigus A., Jarlais D.C.D., Goldstein M.F., Ildefons G. Drug scene roles and HIV risk. Addiction 1998, 93:1403-1416.
14. Hahn J.A., Wylie D., Dill J., Sanchez M.S., Lloyd-Smith J.O., Page-Shafer K., Getz W.M. Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users. Epidemics 2009, 1:47-57.
15. Handcock M.S., Gile K.J. Modeling social networks from sampled data. The Annals of Applied Statistics 2010, 4:5-25.
16. Handcock M.S., Hunter D.R., Butts C.T., Goodreau S.M., Morris M. statnet: Software Tools for the Statistical Modeling of Network Data, Version 2.0. Seattle, WA 2003.
17. Hunter D.R., Goodreau S.M., Handcock M.S. Goodness of fit of social network models. Journal of the American Statistical Association 2008, 103:248-258.
18. Hunter D.R., Handcock M.S. Inference in curved exponential family models for networks. Journal of Computational and Graphical Statistics 2006, 15:565-583.
19. Hutchinson S., Bird S., Taylor A., Goldberg D. Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: implications for prevention. International Journal of Drug Policy 2006, 17:211-221.
20. Iversen J., Maher L. Australian Needle and Syringe Survey National Data Report 2007-2011 2012, The Kirby Institute, University of New South Wales.
21. Iversen J., Topp L., Shying K., Maher L. Australian Needle and Syringe Survey National Data Report 2005-2009 2010, National Centre in HIV Epidemiology and Clinical Research.
22. Iversen J., Topp L., Maher L. Australian Needle and Syringe Survey National Data Report 2002-2006 2007.
23. Khan, B., Dombrowski, K., Saad, M.K., 2012. Modeling of dynamic risk networks and applications to HIV stabilization (submitted for publication), Formerly available at http://snrg-nyc.org/?p=614. Accessed March 30, 2012.
24. Koopman J. Modeling infection transmission. Annual Review of Public Health 2004, 25:303-326.
25. Krivitsky P.N., Handcock M.S., Morris M. Adjusting for network size and composition effects in exponential-family random graph models. Statistical Methodology 2011, 8:319-339.
26. Maher L., Jalaludin B., Chant K.G., Jayasuriya R., Sladden T., Kaldor J.M., Sargent P.L. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction 2006, 101:1499-1508.
27. May R.M., Lloyd A.L. Infection dynamics on scale-free networks. Physical Review E 2001, 64:066112.
28. Meyers L.A. Contact network epidemiology: bond percolation applied to infectious disease prediction and control. Bulletin of the American Mathematical Society 2006, 44:63-87.
29. Miller E., Hellard M., Bowden S., Bharadwaj M., Aitken C. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia. Journal of Infection 2009, 58:375-382.
30. Miller J.C. Spread of infectious disease through clustered populations. Journal of the Royal Society Interface 2009.
31. Murray J.M., Law M.G., Gao Z., Kaldor J.M. The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users. International Journal of Epidemiology 2003, 32:708-714.
32. NCHECR Return on Investment 2: Evaluating the Cost-effectiveness of Needle and Syringe Programs in Australia 2009, National Centre in HIV Epidemiology and Clinical Research.
33. Neaigus A., Friedman S.R., Goldstein M., Ildefonso G., Curtis R., Jose B. Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. NIDA Research Monographs 151 1995, 20-37.
34. Newman M.E.J. Spread of epidemic disease on networks. Physical Review E 2002, 66:016128.
35. Newman M.E.J. Properties of highly clustered networks. Physical Review E 2003, 68:026121.
36. Pastor-Satorras R., Vespignani A. Epidemic spreading in scale-free networks. Physical Review Letters 2001, 86:3200-3203.
37. Pattison P.E., Robins G.L., Snijders T.A.B., Wang P. Conditional estimation of exponential random graph models from snowball and other sampling designs. Technical Report 2012, Melbourne School of Psychological Sciences, University of Melbourne.
38. Pollack H.A. Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users. Medical Decision Making 2001, 21:357-367.
39. Robins G., Pattison P., Kalish Y., Lusher D. An introduction to exponential random graph (p*) models for social networks. Social Networks 2007, 29:173-191.
40. Robins G., Pattison P., Wang P. Closure, connectivity and degree distributions: Exponential random graph (p*) models for directed social networks. Social Networks 2009, 31:105-117.
41. Robins G., Pattison P., Woolcock J. Small and other worlds: global network structures from local processes. American Journal of Sociology 2005, 110:894-936.
42. Robins G., Snijders T., Wang P., Handcock M., Pattison P. Recent developments in exponential random graph (p*) models for social networks. Social Networks 2007, 29:192-215.
43. Rolls D., Daraganova G., Sacks-Davis R., Hellard M., Jenkinson R., McBryde E., Pattison P., Robins G. Modelling hepatitis C transmission over a social network of injecting drug users. Journal of Theoretical Biology 2012, 297:73-87.
44. Sacks-Davis R., Daraganova G., Aitken C., Higgs P., Tracy L., Bowden S., Jenkinson R., Rolls D., Pattison P., Robins G., Grebely J., Barry A., Hellard M. Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs. PLoS ONE 2012, 7:e47335.
45. Salomon J.A., Weinstein M.C., Hammitt J.K., Goldie S.J. Empirically calibrated model of hepatitis C virus infection in the United States. American Journal of Epidemiology 2002, 156:761-773.
46. Snijders T., Pattison P., Robins G., Handcock M. New specifications for exponential random graph models. Sociological Methodology 2006, 36:99-153.
47. Snijders T.A.B. Conditional marginalization for exponential random graph models. Journal of the Mathematical Society 2010, 34:239-252.
48. Snijders T.A.B., Steglich C.E.G., Schweinberger M., Huisman M. Manual for SIENA Version 3.1 2007.
49. Strauss D. On a general class of models for interaction. SIAM Review 1986, 28:513-527.
50. Vickerman P., Hickman M., Judd A. Modelling the impact on hepatitis C transmission of reducing syringe sharing: London case study. International Journal of Epidemiology 2007, 36:396-405.
51. Vickerman P., Platt L., Hawkes S. Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan. Sexually Transmitted Infections 2009, 85:ii23-ii30.
52. Victoria Department of Health Needle and syringe distribution database 2005-2007 2010, Mental Health, Drugs and Regions Division, Unpublished data.
53. Volz E.M., Miller J.C., Galvani A., Ancel Meyers L. Effects of heterogeneous and clustered contact patterns on infectious disease dynamics. PLoS Computational Biology 2011, 7.
54. Wang P., Robins G., Pattison P. Pnet: A Program for the Simulation and Estimation of Exponential Random Graph Models 2006, University of Melbourne.
55. Welch D., Bansal S., Hunter D.R. Statistical inference to advance network models in epidemiology. Epidemics 2011, 3:38-45.
56. Wylie J., Shah L., Jolly A. Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in W innipeg, Canada. BMC Public Health 2006, 6:229.
57. Young A.M., Jonas A.B., Havens J.R. Social networks and HCV viraemia in anti-HCV-positive rural drug users. Epidemiology and Infection 2013, 141:402-411. 10.1017/S0950268812000696.